What is primary prevention with aspirin?

What is primary prevention with aspirin?

In the broader setting of primary prevention, the 2019 American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend that “Low-dose aspirin (75–100 mg orally daily) […] be considered for the primary prevention of ASCVD among select adults of 40 to 70 years of age who are at higher CV risk but …

What are the new aspirin guidelines?

The U.S. Preventive Services Task Force (USPSTF) recently finalized new recommendations for using low-dose aspirin as a means of broadly preventing heart disease and its life-threatening complications, advising against initiating daily aspirin in adults 60 years or older, in particular.

How do you calculate 10-year Ascvd risk?

The 10-year risk estimate for “optimal risk factors” is represented by the following specific risk factor numbers for an individual of the same age, sex and race: Total cholesterol of ≤ 170 mg/dL, HDL-cholesterol of ≥ 50 mg/dL, untreated systolic blood pressure of ≤ 110 mm Hg, no diabetes history, and not a current …

When do you stop taking aspirin for primary prevention?

The new recommendation is as follows: For adults age 40-59 with a 10% or greater risk of heart disease, they do not recommend universal use of daily aspirin, instead suggesting that this be an individual decision made between patients and clinicians.

When do you start aspirin prophylaxis?

The USPSTF recommends initiating low-dose aspirin use for the primary prevention of cardiovascular disease (CVD) and colorectal cancer (CRC) in adults aged 50 to 59 years who have a 10% or greater 10-year CVD risk, are not at increased risk for bleeding, have a life expectancy of at least 10 years, and are willing to …

What is new aspirin?

Valazore, a new type of aspirin, was FDA-approved in March 2021 and is available over the counter (OTC). Compared to traditional aspirin, Vazalore has been shown to cause fewer stomach-related side effects, such as ulcers and damage to the stomach.

What is a normal ASCVD score?

A 0 to 4.9 percent risk is considered low. Eating a healthy diet and exercising will help keep your risk low. Medication is not recommended unless your LDL, or “bad” cholesterol, is greater than or equal to 190.

How accurate is ASCVD risk calculator?

The new AHA-ACC-ASCVD tool overestimated risk by 86%. In female participants, the FRS-CHD, FRS-CVD, ATPIII-FRS-CHD, and AHA-ACC-ASCVD calculators also overestimated risk at all levels of cardiovascular risk. In contrast, the RRS underestimated risk by 21%.

When do you initiate aspirin?

Daily low-dose aspirin therapy may be recommended for the primary prevention of heart attack or stroke if: You’re between ages 40 and 59 and you’re at high risk (10% or greater) of having a first-time heart attack or stroke within the next 10 years.

What are the nursing considerations and patient teaching for aspirin?

Nursing Care Plan for Patients on Aspirin

Aspirin Nursing Interventions Rationale
Advise the patient to prevent drinking excessive amounts of alcohol while on aspirin. Aspirin combined with excessive amounts of alcohol may cause gastrointestinal upset and GI bleeding as evidenced by hematemesis, nausea and vomiting.

What is the 2021-2022 USPSTF recommendation for primary prevention aspirin use?

The 2021-2022 USPSTF recommendation changed its recommendation for primary prevention aspirin use. Specifically, it recommends individual decision making for patients aged 40-59 years at increased risk of CVD and discourages use for patients aged ≥60 years.

When should primary prevention aspirin be used in patients aged 50-59?

Several guidelines and guidance documents, including the 2016 USPSTF, recommended use of primary prevention aspirin for patients aged 50-59 years at elevated CVD risk without bleeding (Grade B).

Is aspirin effective for primary prevention?

In 2018, three key trials of primary prevention with aspirin were published. First, the ASPREE trial found that among healthy older patients (aged ≥65 years), use of low-dose daily aspirin was associated with increased risk for mortality (5.9% vs. 5.2% for placebo at median 4.7 years) and cancer mortality (3.1% vs. 2.3%).

Should low-dose aspirin be considered for primary prevention of ASCVD?

“Low-dose aspirin might be considered for primary prevention of ASCVD in select higher ASCVD adults aged 40-70 years who are not at increased bleeding risk Low-dose aspirin should not be administered on a routine basis for primary prevention of ASCVD among adults > 70 years.